VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 201 filers reported holding VAXCYTE INC in Q3 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,253,571 | -43.9% | 44,205 | -45.1% | 0.00% | – |
| Q2 2023 | $4,019,621 | -44.4% | 80,489 | -58.3% | 0.00% | -100.0% |
| Q1 2023 | $7,230,079 | -53.0% | 192,905 | -39.8% | 0.00% | -50.0% |
| Q4 2022 | $15,370,756 | +359.2% | 320,558 | +129.9% | 0.00% | – |
| Q3 2022 | $3,347,000 | +37.3% | 139,456 | +24.5% | 0.00% | – |
| Q2 2022 | $2,438,000 | +186.2% | 112,031 | +217.7% | 0.00% | – |
| Q1 2022 | $852,000 | -38.4% | 35,260 | -39.3% | 0.00% | – |
| Q4 2021 | $1,382,000 | +103.5% | 58,088 | +117.0% | 0.00% | – |
| Q3 2021 | $679,000 | +59.4% | 26,766 | +41.3% | 0.00% | – |
| Q2 2021 | $426,000 | +29.1% | 18,936 | +13.4% | 0.00% | – |
| Q1 2021 | $330,000 | – | 16,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
| Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
| Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
| RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
| Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
| Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |